Yesterday, a federal jury in Manhattan found Matthew Martomo, a former trader at SAC Capital, guilty on two counts of securities fraud and one count of conspiracy related to an insider trading scheme. The scheme allegedly involved Martomo receiving and trading on inside information he obtained from doctors related to a pharmaceutical trial for an Alzheimer’s drug.
Here are the key facts you need to know.
Subscribe
‘Enforcement 40’ for 2020
Our Sponsors
Join Us On LinkedIn
Join the Securities Litigation and Enforcement Group on LinkedIn